BBNX

Beta Bionics, Inc. Common Stock

21.77

USD

+0.34

+1.59%

Sep 18, 14:21 UTC -4

Open

Beta Bionics, Inc. Common Stock Profile

About

Beta Bionics Inc. is a commercial-stage medical device company engaged in the design, development and commercialization of solutions. Beta Bionics Inc. is based in IRVINE, Calif.

Info & Links

CEO

Sean Saint

Headquarters

11 HUGHES
IRVINE, CA 92618, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

674

Employees

423

Beta Bionics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

979.47M

Enterprise Value

935.05M

Enterprise Value/EBITDA(ttm)

-12.08

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

8.38

Price to Book(mrq)

3.89

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

58.25%

Operating Margin(ttm)

-61.31%

Profit Margin(ttm)

-61.60%

Return on Equity(ttm)

-26.30%

Return on Invested Capital(ttm)

-26.70%

Return on Assets(ttm)

-23.25%

Income Statement

Revenue(ttm)

119.01M

Revenue Per Share(ttm)

2.65

Gross Profit(ttm)

69.40M

EBITDA(ttm)³

-77.38M

Net Income Available to Common(ttm)

-72.97M

Diluted EPS(ttm)

-1.65

Share Statistics

Beta (5Y Monthly)

3.37

52-Week Change

-5.79%

S&P 500 52-Week Change

17.10%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

44.99M

Dividend Yield

0.00%

Float⁴

42.61M

% Held by Insiders

5.30%

% Held by Institutions

Balance Sheet

Total Cash(mrq)

180.59M

Total Cash Per Share(mrq)

4.01

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

8.88%

Quick Ratio(mrq)

7.96%

Book Value Per Share(mrq)

5.70

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.86

Free Cash Flow(ytd)

-40.87M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.